Clinical trials
Not yet recruiting Prostatic Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 38 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Power Life Sciences Inc. | 3 |
| University of Nebraska | 3 |
| Washington University School of Medicine | 3 |
| Case Comprehensive Cancer Center | 2 |
| Emory University | 2 |
| Fred Hutchinson Cancer Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| NYU Langone Health | 2 |
| University of Miami | 2 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 49 |
| Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Neoplasm Metastasis | 3 |
| Breast Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Anus Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.